|1.||Rogler, Gerhard: 5 articles (09/2013 - 01/2007)|
|2.||Kalyuzhin, O V: 4 articles (05/2015 - 05/2003)|
|3.||Rosenstiel, Philip: 4 articles (01/2012 - 01/2007)|
|4.||Schreiber, Stefan: 4 articles (01/2012 - 01/2007)|
|5.||Langford, Marlyn P: 3 articles (11/2013 - 09/2003)|
|6.||Fried, Michael: 3 articles (01/2013 - 05/2012)|
|7.||Till, Andreas: 3 articles (01/2012 - 02/2008)|
|8.||Kalina, N G: 3 articles (10/2009 - 05/2003)|
|9.||Mulik, E L: 3 articles (10/2009 - 01/2008)|
|10.||Netea, Mihai G: 3 articles (12/2008 - 10/2005)|
01/01/1989 - "The purpose of this study was to compare CPV with muramyl dipeptide (MDP), an immunomodulator of proven efficacy in simulated surgical infection. "
06/01/1987 - "Prophylactic treatment with N-acetylmuramyl-L-alanyl-d-isoglutamine gave significant protection against Streptococcus pneumoniae, Salmonella typhimurium, and Salmonella enteritidis infection. "
08/01/1985 - "Muramyl dipeptide (MDP) is an immunostimulatory agent that has been shown repeatedly to provide protection against the effects of some forms of experimental surgical infection. "
04/01/1983 - "Studies were carried out to determine whether treatment of mice with the synthetic adjuvant muramyl dipeptide (MDP) afforded resistance to infection with Mycobacterium leprae or M. "
02/01/1981 - "Studies were carried out to determine whether treatment of mice with the synthetic adjuvant muramyl dipeptide afforded any resistance to infection with the obligate intracellular protozoan Toxoplasma gondii. "
04/01/2002 - "The treatment with activated macrophages (activated by using Muramyl dipeptide) significantly reduced the secondary growth of tumor in lung. "
11/01/2001 - "Muramyl dipeptide (MDP)-Lys (L18), a synthetic MDP analogue derived from bacterial cell walls, has been reported to be a potent immunoadjuvant that enhances protective immunity against pathogens and tumors by stimulating immune-competent cells, such as monocytes and macrophages. "
12/04/1996 - "Liposomal phosphatidylserine inhibits tumor cytotoxicity of liver macrophages induced by muramyl dipeptide and lipopolysaccharide."
06/15/1994 - "Since muramyl dipeptide (MDP) was recognized as a potent monocyte/macrophage activating agent, many MDP analogues were synthesized and tested for their ability to augment the host immune defence system against neoplasms. "
04/01/1994 - "Tumor cell binding and induction of endothelial cell tumoricidal activity in vitro by muramyl dipeptide is enhanced by liposomal encapsulation."
|3.||Neoplasm Metastasis (Metastasis)
01/01/1991 - "Liposomal muramyl dipeptide therapy of experimental M5076 liver metastases in mice."
01/01/1990 - "In a reproducible murine model of liver metastases, it was demonstrated that liposomal muramyl dipeptide (MDP) as an adjuvant therapy reduces and prevents the development of metastases. "
02/15/1989 - "Liposomal muramyl dipeptide therapy using lipophilic derivatives would appear to be an effective treatment for hepatic metastases derived from primary tumors."
04/01/1984 - "A new lipophilic muramyl dipeptide analog, 6-O-stearoyl-N-acetylmuramyl-L-alpha-aminobutyryl-D-isoglutamine, when incorporated in liposomes, was effective in both the prevention and eradication of experimental pulmonary metastases in mice. "
04/28/2011 - "1 (MTC-220), a conjugate of paclitaxel and a muramyl dipeptide analogue, has been synthesized as a novel agent of dual antitumor growth and metastasis activities. "
|4.||Sarcoma (Soft Tissue Sarcoma)
01/01/1986 - "In vivo effects of toxic and detoxified endotoxin alone or in combination with muramyl dipeptide on lymphoid and non-lymphoid cells in the spleen of Meth A sarcoma-bearing mice."
01/01/1986 - "In this study we confirmed that combinations of toxic or detoxified endotoxin with muramyl dipeptide (MDP) induced much more necrosis of transplanted Meth A sarcoma in mice than toxic endotoxin alone. "
01/01/1984 - "The previously observed potentiation of necrosis and regression of solid immunogenic Meth A sarcoma transplants in mice after IV administration of endotoxin by addition of muramyl dipeptide (MDP) in saline was investigated further by varying time and route of administration of both agents. "
08/01/1984 - "The direct cell-mediated antitumor cytotoxicity induced by coupling a murine methylcholanthrene-induced sarcoma with N-acetylmuramyl-L-alanyl-D-isoglutamine (adjuvant peptide) was eliminated by treatment of effector cells with anti-Thy 1.2 or anti-Lyt 2.2 monoclonal antibody and complement. "
|5.||Influenza in Birds (Avian Flu)
|6.||R 848 (resiquimod)